Patents Assigned to Beyond Barriers Therapeutics, Inc.
  • Enhanced delivery of antioxidants for treatment of central nervous system disorders involving oxidative stress
    Patent number: 11612642
    Abstract: The present disclosure generally relates to methods and formulations for treating central nervous system (CNS) disorders. The present disclosure involves intranasal delivery of at least one antioxidant compound, allowing for effective treatment of a central nervous system disorder such as traumatic brain injury or stroke.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: March 28, 2023
    Assignee: Beyond Barriers Therapeutics, Inc.
    Inventors: Ryan Kole, John Marshall, Meriel Owen